Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Stargus

Explore full profile

Stargus was founded in June 2000 with the goal of addressing the need for comprehensive network and service management solutions

United StatesFounded 2000
Valuation $50–100M Last recorded · 2001
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Stargus and the history behind them.

About Stargus

Stargus is a prominent biofungicide developed by Marrone Bio Innovations (MBI), a company that carved a significant niche in the agricultural technology sector. Founded in 2006 by Dr. Pamela Marrone, MBI focused on discovering, developing, and promoting sustainable biopesticides and plant health products. Dr. Marrone, a serial entrepreneur with a PhD in entomology and a deep background in pesticide discovery, leveraged her expertise to build a company centered on providing growers with biologically-based alternatives to conventional chemical pesticides. Her journey was driven by a vision to create an agricultural system where effective pest and disease control could coexist with environmental stewardship.

The company's core business revolves around the research, development, and commercialization of environmentally responsible agricultural products for crop protection, plant health, and nutrition. MBI serves a global client base of growers and farmers in the conventional, transitional, and organic markets. Its business model is based on the sale of its proprietary products through a network of distribution partners worldwide. Revenue is generated from product sales to these distributors, who then supply them to agricultural retailers and directly to large farming operations. Following years of growth and establishing a strong market presence, Marrone Bio Innovations went public (NASDAQ: MBII) and was later acquired by Bioceres Crop Solutions in 2022, and is now a key part of the ProFarmGroup, which continues to advance its portfolio of biological crop solutions.

The Stargus product itself is a biofungicide containing the active ingredient *Bacillus amyloliquefaciens* strain F727. It offers growers a broad-spectrum solution for controlling challenging fungal and bacterial diseases such as downy mildew, Botrytis, and white mold across a wide variety of crops including leafy greens, grapes, and strawberries. Its primary benefit lies in its multiple modes of action, which help in managing resistance to traditional fungicides. Stargus operates by colonizing plant surfaces to prevent pathogens from establishing themselves and by stimulating the plant's own defense mechanisms. A key selling point is its favorable safety and handling profile; it is MRL-exempt, meaning no maximum residue limits to worry about, and features a 0-day pre-harvest interval, allowing for application right up to the day of harvest. This provides growers with significant flexibility in their integrated pest management (IPM) programs.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2000
Headquarters
United States
Open positions
None listed
Dealroom signal
13.7/100
Client focus
b2b
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jul 2004 $0 — C-COR —
SEEDOther financing Jan 2001 $10M $40M Castile Ventures · Pilot House Ventures · Richard Lauder —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Stargus website traffic

Latest recorded traffic for Stargus is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Castile Ventures
  • Pilot House Ventures
  • Richard Lauder

Other known investors1 additional known investor

  • C-COR
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Stargus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stargus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.